Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 221-234, June 2006

Treatment of hirsutism and acne in hyperandrogenism

  • Paolo Moghetti, MD, PhD (Associate Professor of Endocrinology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 045 8073110; Fax: +39 045 917374.

Division of Endocrinology and Metabolic Diseases, University of Verona, Ospedale Maggiore, P. le Stefani 1, 37126 Verona, Italy

Endocrinology, 2nd Faculty of Medicine, University ‘La Sapienza’, Rome, Italy

Hirsutism and acne are common and highly distressing complaints in women with polycystic ovary syndrome (PCOS). Drugs are only partially effective on terminalized hairs, and removal of these hairs is usually required. Therefore, management of hirsutism is generally based upon a dual approach: a pharmacological therapy to reduce androgen secretion and/or androgen action, and removal of terminal hair already present. Ovarian suppression of androgen secretion with oral contraceptives is widely used in these women, but its efficacy appears limited. The most effective medical therapy for hirsutism is by anti-androgen drugs. Electrolysis and laser photothermolysis are considered the most effective cosmetic procedures, although the effects of these methods should not be considered permanent. Acne may be treated with different tools, according to the severity of the condition and other characteristics of the patient. These tools include topical and systemic retinoids and antibiotics, topical antibacterial agents, androgen suppression by oral contraceptives, and anti-androgen drugs.

Key words: hirsutism, acne, anti-androgen drugs, oral contraceptives, cosmetic procedures, retinoids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(06)00025-X

doi:10.1016/j.beem.2006.03.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 221-234, June 2006